We are live on ! Find out more
KA

Klingman & Associates Portfolio holdings

AUM $2.09B
1-Year Est. Return 16.49%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+16.49%
3 Year Est. Return
+47.09%
5 Year Est. Return
+51.57%
10 Year Est. Return
+158.57%
AUM
$309M
AUM Growth
+$30.1M
Cap. Flow
+$15.6M
Cap. Flow %
5.06%
Top 10 Hldgs %
63.46%
Holding
407
New
11
Increased
29
Reduced
46
Closed
17
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCT
26
First Trust Senior Floating Rate Income Fund II
FCT
$251M
$1.8M 0.58%
139,762
-4,000
-3% -$51.5K
HDV
27
iShares Core High Dividend ETF
HDV
$14.4B
$1.78M 0.58%
108,335
-5,700
-5% -$90.8K
MLPX icon
28
Global X MLP & Energy Infrastructure ETF
MLPX
$3.68B
$1.77M 0.57%
42,850
-814
-2% -$31K
CFG icon
29
Citizens Financial Group
CFG
$30.4B
$1.69M 0.55%
84,500
VEU icon
30
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$1.66M 0.54%
38,824
+67
+0.2% +$2.9K
RY icon
31
Royal Bank of Canada
RY
$291B
$1.56M 0.5%
26,355
XOM icon
32
ExxonMobil
XOM
$651B
$1.39M 0.45%
14,845
-103
-0.7% -$9.11K
JPM icon
33
JPMorgan Chase
JPM
$939B
$1.37M 0.44%
22,078
-952
-4% -$59.5K
VWO icon
34
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.29M 0.42%
36,671
+33
+0.1% +$1.13K
FRA icon
35
BlackRock Floating Rate Income Strategies Fund
FRA
$381M
$1.17M 0.38%
88,863
GE icon
36
GE Aerospace
GE
$367B
$1.01M 0.33%
6,731
VEA icon
37
Vanguard FTSE Developed Markets ETF
VEA
$226B
$886K 0.29%
25,065
+37
+0.1% +$1.34K
RWK icon
38
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.3B
$843K 0.27%
17,664
DEM icon
39
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.88B
$824K 0.27%
23,255
+764
+3% +$26.4K
VIG icon
40
Vanguard Dividend Appreciation ETF
VIG
$111B
$784K 0.25%
9,414
+13
+0.1% +$1.06K
RWX icon
41
State Street SPDR Dow Jones International Real Estate ETF
RWX
$265M
$731K 0.24%
17,645
-230
-1% -$9.62K
EMD
42
Western Asset Emerging Markets Debt Fund
EMD
$609M
$720K 0.23%
46,782
IDLV icon
43
Invesco S&P International Developed Low Volatility ETF
IDLV
$338M
$676K 0.22%
22,600
PFE icon
44
Pfizer
PFE
$140B
$664K 0.21%
19,878
-165
-0.8% -$5.27K
OEF icon
45
iShares S&P 100 ETF
OEF
$19.8B
$644K 0.21%
6,929
-81
-1% -$7.47K
SCZ icon
46
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
$638K 0.21%
13,229
-948
-7% -$47.6K
VB icon
47
Vanguard Small-Cap ETF
VB
$79.5B
$630K 0.2%
5,445
-209
-4% -$23.7K
VRP icon
48
Invesco Variable Rate Preferred ETF
VRP
$2.99B
$629K 0.2%
25,335
+435
+2% +$10.6K
RWJ icon
49
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.03B
$622K 0.2%
33,888
-510
-1% -$9.29K
CHY
50
Calamos Convertible and High Income Fund
CHY
$1.03B
$572K 0.19%
53,871
-1,434
-3% -$14.8K

Similar funds

Klingman & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Klingman & Associates held 407 positions worth $309M, up 11% from $279M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Klingman & Associates deployed $15.6M of net new capital in Q2 2016, opening 11 new positions and adding to 29 existing holdings. Its largest new stake was Invesco BulletShares 2022 Corporate Bond ETF: 8,460 shares worth $182K.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 4.7% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.73M trimmed.

  • Klingman & Associates's largest Q2 2016 buy was Invesco BulletShares 2022 Corporate Bond ETF: 8,460 shares worth $182K.
  • Klingman & Associates added most to iShares Core S&P 500 ETF in Q2 2016, an estimated $7.65M increase.
  • Klingman & Associates's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.73M.
  • Klingman & Associates fully exited Endurance Specialty Holdings Ltd in Q2 2016, selling an estimated $2.64M.
  • Klingman & Associates's ten largest holdings make up 63% of its $309M portfolio in Q2 2016.
  • Klingman & Associates opened 11 new positions and closed 17 in Q2 2016.
  • Klingman & Associates's portfolio value rose 11% quarter-over-quarter to $309M.

Based on Klingman & Associates's 13F filing for Q2 2016, filed 4 Aug 2016.